Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and Aβ expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer’s disease: A pilot study-Reference-Cited by-同舟云学术

Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and Aβ expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer’s disease: A pilot study

Published:2018-08 Issue: Volume:104 Page:211-222
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

G. Vinothkumar,S. Krishnakumar,Sureshkumar ,G. Shivashekar,S. Sreedhar,Preethikrishnan ,S. Dinesh,A. Sundaram,D. Balakrishnan,Riya ,P. Venkataraman

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference58 articles.

1. Cognitive impairment in CKD: keep vascular disease in mind: commentary for kidney international on ‘cognitive impairment in chronic kidney disease: prevalence, severity and association with HbA1c and fibrinogen’;Drew;Kidney Int.,2014

2. Cognitive alterations in chronic kidney disease: an update;Matta;J. Bras. Nefrol.,2014

3. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment;Butterfield;Free Radic. Biol. Med.,2007

4. Platelet β-secretase activity is increased in Alzheimer’s disease;Johnston;Neurobiol. Aging,2008

5. ADAM 10 and BACE alterations in the early stages of Alzheimer disease;Colciaghi;Neurology,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAM10 isoforms: Optimizing usage of antibodies based on protein regulation, structural features, biological activity and clinical relevance to Alzheimer’s disease;Ageing Research Reviews;2024-11

2. Neuroprotective effect of erythropoietin on anesthesia-induced neurotoxicity through the modulation of autophagy in Caenorhabditis elegans;Korean Journal of Anesthesiology;2024-06-01

3. Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review;Pharmacological Research;2024-05

4. ADAM10 as a biomarker for Alzheimer's disease: A systematic review;Revue Neurologique;2024-01

5. A novel high-efficiency transdermal patches for combinational therapy of Alzheimer's disease: Donepezil/vitamin B12-loaded nanofibers;Journal of Drug Delivery Science and Technology;2023-11